SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-007207
Filing Date
2023-01-12
Accepted
2023-01-12 16:31:28
Documents
5
Effectiveness Date
2023-01-12

Document Format Files

Seq Description Document Type Size
1 S-8 d342838ds8.htm S-8 43130
2 EX-5.1 d342838dex51.htm EX-5.1 7598
3 EX-23.1 d342838dex231.htm EX-23.1 1476
4 EX-FILING FEES d342838dexfilingfees.htm EX-FILING FEES 18785
5 GRAPHIC g342838g0105051737967.jpg GRAPHIC 2231
  Complete submission text file 0001193125-23-007207.txt   75237
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269204 | Film No.: 23526229
SIC: 2836 Biological Products, (No Diagnostic Substances)